The escalating global prevalence of obesity and type 2 diabetes mellitus (T2DM) underscores the urgent need for innovative ...

As obesity rates rise among individuals with T1D, GLP-1 agonist medications, indicated for T2D and weight loss, are ...

In the search for better ways to treat diabetes, researchers at the University of Geneva have uncovered a promising new ...

SaveHealth explores what the research says about Ozempic's effects on insulin resistance and related conditions.

A study led by two undergraduate students at the University of Galway found that GLP-1 receptor agonists, a type of diabetes ...

The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a ...

Scientists at Case Western Reserve University and University Hospitals have made an exciting discovery that may change how we ...

Susan Weiner, MS, RDN, CDN, CDCES, FADCES, talks with Linda Gigliotti, MS, RDN, CDCES, FAND, about combining the use of GLP-1 ...

Popular prescription weight-loss drugs called GLP-1 receptor agonists are now frequently used by type 1 diabetes patients, despite limited data on the drugs’ safety and effectiveness in this patient ...

"It was encouraging that even people using insulin plus a GLP-1 receptor agonist drug, such as Ozempic [semaglutide], had substantial A1C improvement with the addition of Control-IQ+ to their ...